Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03296657 · ClinicalTrials.gov registry record · NA
Analysis of Stannous Fluoride in GCF and Subgingival Plaque
A NA study of Subgingival Plaque and GCF, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03296657 is a NA study of Subgingival Plaque and GCF that has completed, run by Procter and Gamble. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03296657, a NA study of Subgingival Plaque and GCF, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The amount of stannous fluoride in GCF and subgingival plaque samples will be analyzed.
Conditions Studied
Interventions
- DRUG stannous fluoride
Study Locations (1)
Indiana
- Salus Research - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2017-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03296657
The ClinicalTrials.gov registry entry for NCT03296657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Subgingival Plaque appearing as the primary indexed condition, and to 1 intervention - of which stannous fluoride is the first listed.
NCT03296657 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03296657 about?
NCT03296657 is a clinical study titled "Analysis of Stannous Fluoride in GCF and Subgingival Plaque". The amount of stannous fluoride in GCF and subgingival plaque samples will be analyzed.
What is the current status of trial NCT03296657?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-08-23. Estimated completion is 2017-09-22.
What conditions does trial NCT03296657 study?
This clinical trial studies the following conditions: Subgingival Plaque, GCF.
What interventions are being tested in trial NCT03296657?
The interventions under investigation include: stannous fluoride (DRUG).
Who is sponsoring clinical trial NCT03296657?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03296657 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.